<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="correction" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">34573</article-id><article-id pub-id-type="doi">10.7554/eLife.34573</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Correction</subject></subj-group></article-categories><title-group><article-title>Correction: Replication Study: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-34765"><name><surname>Shan</surname><given-names>Xiaochuan</given-names></name></contrib><contrib contrib-type="author" id="author-34763"><name><surname>Fung</surname><given-names>Juan José</given-names></name><email>jjfung@pronovusbio.com</email></contrib><contrib contrib-type="author" id="author-34764"><name><surname>Kosaka</surname><given-names>Alan</given-names></name><email>akosaka@pronovusbio.com</email></contrib><contrib contrib-type="author" id="author-34766"><name><surname>Danet-Desnoyers</surname><given-names>Gwenn</given-names></name><email>gdanet@mail.med.upenn.edu</email></contrib><contrib contrib-type="author" corresp="yes"><email>tim@cos.io</email><collab>Reproducibility Project: Cancer Biology</collab></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>08</day><month>01</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>7</volume><elocation-id>e34573</elocation-id><history><date date-type="received" iso-8601-date="2018-01-03"><day>03</day><month>01</month><year>2018</year></date><date date-type="accepted" iso-8601-date="2018-01-03"><day>03</day><month>01</month><year>2018</year></date></history><permissions><copyright-statement>© 2018, Shan et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Shan et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><related-article ext-link-type="doi" id="ra1" related-article-type="corrected-article" xlink:href="10.7554/eLife.25306"/></article-meta></front><body><boxed-text><p>Shan X, Fung JJ, Kosaka A, Danet-Desnoyers G, Reproducibility Project: Cancer Biology. 2017. Replication Study: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. <italic>eLife</italic> <bold>6</bold>:e25306. doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.7554/eLife.25306">10.7554/eLife.25306</ext-link>.</p><p>Published 27, June 2017</p></boxed-text><p>This is a corrigendum for Replication Study: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia, which includes the following corrections:</p><p>First, the direction of the effect size calculated for the Replication Study’s comparison of fold <italic>BCL2</italic> expression in K-562 cells compared to a DMSO constant of 1 (Figure 5A, top panel) is incorrect. The direction of the effect size (Cohen’s <italic>d</italic>) for this comparison should be <italic>d</italic> = −2.04 95% CI [−4.17, 0.13] (instead of the reported <italic>d</italic> = 2.04 95% CI [−0.13, 4.17]), which results in a change in the meta-analysis. The meta-analysis effect size should be <italic>d</italic> = −0.307, 95% CI [−3.57, 2.96], <italic>p</italic> =0.854 (instead of the reported <italic>d</italic> = 1.58, 95% CI [0.36, 2.79], <italic>p</italic>=0.011).</p><p>Second, the calculation of variance in the meta-analysis of mice treated daily with I-BET151 compared to vehicle control mice (Figure 5C) is incorrect. Subsequently, the effect size and the associated <italic>p</italic> value of the meta-analysis are incorrect. The effect size (Hazard Ratio) for this comparison should be HR = 3.30 95% CI [0.49, 22.18] (instead of the reported HR = 6.13 95% CI [1.11, 34.02]) resulting in a p value of <italic>p</italic>=0.220 (instead of the reported <italic>p</italic> = 0.038).</p><p>Finally, the language surrounding these comparisons in the Results and Discussion section as well as in Figure 5 and the Figure Legend (Figure 5) have been amended to account for these corrections. Additional r code for the meta-analysis can be found on the Open Science Framework: <ext-link ext-link-type="uri" xlink:href="https://osf.io/vfp47/">https://osf.io/vfp47/</ext-link>.</p><p>The corrected Figure 5 is shown here:</p><fig id="fig1" position="float"><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-34573-fig1-v1"/></fig><p>The originally published Figure 5 is also shown for reference:</p><fig id="fig2" position="float"><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-34573-fig2-v1"/></fig><p>The article has now been corrected.</p></body></article>